Leptin Analog [EPC]

583 reported adverse events

Drugs of this class: METRELEPTIN

These side effects are most commonly reported by patients taking drugs of the Leptin Analog [EPC] class:

# Side effect Count
0 THERAPY CESSATION 72
1 BLOOD GLUCOSE INCREASED 61
2 WEIGHT DECREASED 49
3 NAUSEA 42
4 DRUG INEFFECTIVE 36
5 INJECTION SITE PAIN 29
6 PRODUCT DOSE OMISSION 29
7 BLOOD TRIGLYCERIDES INCREASED 25
8 CONDITION AGGRAVATED 25
9 ABDOMINAL PAIN 24
See all common reactions for Leptin Analog [EPC]

Drugs of the Leptin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RENAL MALPOSITION 1 0.1667
1 LABORATORY TEST NORMAL 1 0.1250
2 GENITALS ENLARGED 1 0.1111
3 XANTHOMATOSIS 1 0.1000
4 ALPHA TUMOUR NECROSIS FACTOR INCREASED 3 0.0732
5 NASAL MUCOSAL HYPERTROPHY 1 0.0625
6 PSYCHOMOTOR DISADAPTATION SYNDROME 1 0.0588
7 PLICA SYNDROME 1 0.0556
8 POST INFECTION GLOMERULONEPHRITIS 1 0.0526
9 CONGENITAL URINARY TRACT OBSTRUCTION 1 0.0500
See all enriched reactions for Leptin Analog [EPC]